Evexta Bio and Roche have partnered on a Phase Ib study investigating the rupitasertib-giredestrant combination in patients with advanced or metastatic breast cancer.

The post Evexta Bio and Roche plan Phase Ib trial of rupitasertib with giredestrant appeared first on Clinical Trials Arena.